Richard Whitcomb — President and CEO.
Rick’s background is in operations, services, and finance. Prior to joining BiOptix, Rick Whitcomb was Senior Manager of the On Site Services business for Agilent Technologies Electronic Measurement Group. His background also includes several years of Corporate Development experience for Agilent and Hewlett-Packard Co., and he was formerly Operational CFO for the Communications Network Solutions business unit at Agilent. Rick brings substantial international experience, having spent five years living and working in Europe for Agilent and Hewlett-Packard Co. During his career, he has worked with scientists in Agilent Labs and HP Labs to move promising new technologies from the lab into commercialization, and ultimately into the hands of customers.
Marty Stanton — CSO.
Marty has held key leadership roles in biotechnology companies that have translated novel technologies into products to significantly improve patient care. Previously, Marty was the CSO and COO at SomaLogic, where he led the development of SomaLogic’s aptamer-based biomarker discovery platform. Prior to SomaLogic, Marty co-founded Dexela in 2005 to develop three-dimensional medical imaging for the early detection of cancer.
While at Dexela, he served as the President and Head of Research and Development. In 2001, Marty co-founded Archemix Corp., a biopharmaceutical developing aptamer therapeutics located in Cambridge, Massachusetts. While at Archemix, Marty held a number of positions, including President and Executive Vice President. Prior to Archemix, Marty led an applied science research group at Brandeis University that developed a diverse array of applications, including proteomic technologies, x-ray crystallography detectors, and methods and instrumentation for medical imaging.
Marty received his PhD from Brandeis University in Biophysics.
Ken Wilczek — Vice President of Sales and Marketing.
In addition to senior leadership and consulting roles both inside and outside of life sciences, prior to joining BiOptix, Ken was General Manager, Research Antibodies for Thermo Fisher Scientific. In this role, Ken had commercial responsibility for the Thermo Scientific antibody and high content analysis businesses and led the integration of ABR—Affinity BioReagents into the company post-acquisition. Prior to joining Thermo Fisher Scientific, Ken was the President of ABR—Affinity BioReagents, a manufacturer of research antibodies and custom antibody solutions. Ken was instrumental in growing the company and led the expansion of both the product line as well as global sales channels, ultimately positioning the company for divestment in 2008. Ken was also the General Manager for IHS Health Group and related divisions, a SaaS publisher to the life science, medical device and pharmaceutical industries. In addition, Ken held general management roles at Johnson & Johnson, focusing on international market and business development.
Ken holds a Master of International Management degree from Thunderbird School of Global Management and a Bachelor of International Business Administration from The University of Denver.
Nolan Smith — CFO.
Nolan brings over twelve years of financial experience in venture capital and consulting, assurance and advisory services to BiOptix. Prior to joining BiOptix Nolan spent over three years with Boulder Ventures, a venture capital firm focused on early stage investments in technology and life science companies. Prior to his time at Boulder Ventures Nolan served as a Director in the Corporate Finance / Restructuring practice at FTI Consulting, consulting on the strategic, operational, financial and capital needs of distressed businesses. Nolan began his career with PWC, providing assurance and advisory services to both public and venture supported companies in the software, information technology and data storage industries.
Nolan graduated from the University of Kansas with high distinction and is a certified public accountant in the state of Colorado.
Slava Petropavlovskikh — Director of Research and Development, Co-Founder, BiOptix.
Slava is a dual degree graduate in Applied Mathematics (M.S. – Military Academy) and Applied Physics (M.S. – Moscow Institute of Physics and Technology, Moscow, Russia, Aerospace Department). He is a published expert and patent holder in applied physics, optical effects and signal manipulation and a former Science and Technology Manager at Ionics Sievers.
1775 38th St.
Boulder, CO 80301 USA
June 17 - 18
Princeton Marriott at Forrestal
Next Generation Protein Therapeutics Summit
June 26 - 28
Hotel Coronado Resort & Spa
Symposia of the Protein Society
July 20 - 24
Boston Marriott Copley Place